Scarica l'app Stockscreener
0.9899
0.84%
0.0082
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BBLG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.9817
Aprire:
$0.98
Volume 24 ore:
19,248
Relative Volume:
0.09
Capitalizzazione di mercato:
$2.42M
Reddito:
-
Utile/perdita netta:
$-4.14M
Rapporto P/E:
-0.1365
EPS:
-7.2511
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
-1.99%
1M Prestazione:
-11.62%
6M Prestazione:
-13.92%
1 anno Prestazione:
-76.54%
Intervallo 1D:
$0.97
$0.99
Intervallo di 1 settimana:
$0.94
$1.02
Portata 52W:
$0.80
$4.74
Bone Biologics Corp Stock (BBLG) Company Profile
Nome
Bone Biologics Corp
Settore
Industria
Telefono
(781) 552-4452
Indirizzo
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Confronta BBLG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.9899 | 2.42M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
111.66 | 196.03B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
97.00 | 140.97B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
366.89 | 138.31B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
85.33 | 109.31B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.25 | 41.90B | 6.60B | 4.16B | 490.10M | 6.93 |
Bone Biologics Corp Borsa (BBLG) Ultime notizie
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Orthobiologics Devices And Equipment Market Size, Growth, Trends And Forecast To 2033 - openPR
Orthobiologics Market Overall Study Report 2024-2031 | Zimmer - openPR
Bone Biologics updates ATM offering agreement terms By Investing.com - Investing.com Australia
Bone Biologics updates ATM offering agreement terms - Investing.com
Orthobiologics Devices And Equipment Market In-Depth Analysis of the Research Report 2024-2033: Opportuniti... - WhaTech
Orthobiologics Market Growth in Future Scope 2024-2031 | - openPR
(BBLGW) Proactive Strategies - Stock Traders Daily
Bone Biologics Corp (BBLGW) Quarterly 10-Q Report - Quartzy
Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research - OrthoSpineNews
Orthobiologics Market Is Expected To Reach a Revenue Of USD - GlobeNewswire
Learn to Evaluate (BBLGW) using the Charts - Stock Traders Daily
OFIX INVESTORS: OrthoFix Medical Inc. Stockholders Should Contact Robbins LLP About Joining the Pending OFIX Class Action - The Malaysian Reserve
Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt™ SP - OrthoSpineNews
Bone Growth Products Market Insights Report, 2024-2029: - GlobeNewswire
Long Term Trading Analysis for (BBLGW) - Stock Traders Daily
Orthobiologics Global Market Analysis, Trends, Growth, Research And Forecast 2033 - openPR
Spine Biologics Market Report 2024Spine Biologics Market Trends And Share - openPR
BBLGBone Biologics Corp Latest Stock News & Market Updates - StockTitan
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - StockTitan
Therealreal Inc (REAL) Recovers 161.90% From Low: Sitting In The Catbird Seat? - Stocks Register
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
BBLG’s 2023 Market Dance: Down -67.26% – Time to Invest? - The InvestChronicle
Stock Market Recap: Bone Biologics Corp (BBLG) Concludes at 1.48, a -6.92 Surge/Decline - The Dwinnex
Tetrous®Inc. Announces Issue of an Additional U.S. Patent Related to EnFix® Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures - OrthoSpineNews
TETROUS®, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES - PR Newswire
Spain Orthobiologics Market Outlook and Forecast to 2033Orthobiologics, Cartilage Repair and Others - GlobalData
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Ortho Biological Products Market Giants Spending Is Going to Boom - Bacterial Vaccines Market with ...
Bone Biologics announces director resignation - Investing.com India
Bone Biologics announces director resignation By Investing.com - Investing.com South Africa
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Bone Void Fillers Market 2024By Industry Outlook, Future Trends, Growth Analysis And Forecast To 2033 - openPR
Was there any good news for Bone Biologics Corp (BBLG) stock in the last session? - US Post News
Bone Biologics Corp (BBLG) Stock: Navigating a Year of Volatility - The InvestChronicle
Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients - Benzinga
In the Green: Bone Biologics Corp (BBLG) Closes at 1.52, Up/Down -26.92 from Previous Day - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com
Orthobiologics Market Industry Analysis 2024 Future Scope, - openPR
A closer look at BBLG’s price-to-free cash flow ratio - US Post News
Bone Biologics Corp (BBLG) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Wall Street today: US stocks surge stops as investors pause after big US Fed rate cut, Nike gains 6.59% | Stock Market News - Mint
Bone Biologics Corp [BBLG] Is Currently 20.23 above its 200 Period Moving Avg: What Does This Mean? - The DBT News
Orthobiologics Market See Incredible Growth 2024-2031 | Zimmer - openPR
Bone Biologics Corp Azioni (BBLG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):